Skip to content

Molecular Genetics in Infantile Spasms

Molecular Characterization of a Cohort of 73 Patients With Infantile Spasms Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02885389
Enrollment
41
Registered
2016-08-31
Start date
2010-10-31
Completion date
2012-07-31
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Spasms, West Syndrome

Keywords

Infantile spasms, West syndrome, variant, mutation, CNV, sequencing

Brief summary

Infantile Spasms syndrome (ISs) is a characterized by epileptic spasms occurring in clusters with an onset in the first year of life. West syndrome represents a subset of ISs that associates spasms in clusters, a hypsarrhythmia EEG pattern and a developmental arrest or regression. Aetiology of ISs is widely heterogeneous including many genetic causes. Many patients, however, remain without etiological diagnosis, which is critical for prognostic purpose and genetic counselling. In the present study, the investigators performed genetic screening of 73 patients with different types of ISs by array-CGH and molecular analysis of 5 genes: CDKL5, STXBP1, KCNQ2, and GRIN2A, whose mutations cause different types of epileptic encephalopathies, including ISs, as well as MAGI2, which was suggested to be related to a subset of ISs.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 15 Years
Healthy volunteers
No

Inclusion criteria

* Infantile spams or West syndrome

Exclusion criteria

* brain malformation * clinical features of tuberous sclerosis * abnormal metabolic assays

Design outcomes

Primary

MeasureTime frame
Presence of deleterious gene variants in candidate genes for infantile spasms/west syndrome and for deleterious Copy-Number variations (CNV). A pan-genome analysis by microarrayDay one

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026